WHITEHAWK THERAPEUTICS, INC. Accounts Payable and Accrued Liabilities, Current
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Accounts Payable and Accrued Liabilities, Current of $2.20 million as of 2021-06-30, per its 10-Q filed 2021-08-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2021-08-11
- 2021-06-30: Accounts Payable and Accrued Liabilities, Current $2.20M.
- 2021-03-31: Accounts Payable and Accrued Liabilities, Current $2.09M.
- 2020-12-31: Accounts Payable and Accrued Liabilities, Current $1.80M.
- 2020-09-30: Accounts Payable and Accrued Liabilities, Current $2.42M.
| Period end | Accounts Payable and Accrued Liabilities, Current |
|---|---|
| 2021-06-30 | $2.20M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $2.09M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.80M 10-Q · filed 2021-08-11 |
| 2020-09-30 | $2.42M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $2.99M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $2.55M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $3.23M 10-K · filed 2021-03-11 |
| 2019-09-30 | $3.40M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $3.40M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $3.73M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $5.46M 10-K · filed 2020-03-16 |
| 2018-09-30 | $3.64M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $2.97M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $3.62M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $3.59M 10-K · filed 2019-03-07 |
| 2017-09-30 | $2.59M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $1.86M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $2.97M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $2.47M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |